Blackstone hits $4.6bn hard cap for biggest-ever PE fund dedicated to life science deals
Blackstone has raised $4.6bn for the biggest-ever private equity fund dedicated to life sciences investments, hitting its hard cap for the vehicle.
Blackstone has raised $4.6bn for the biggest-ever private equity fund dedicated to life sciences investments, hitting its hard cap for the vehicle.
European life science and healthcare investor LSP has led a €32m Series B financing round for VarmX, a biotech company focused on developing approaches for the reversal of anticoagulation.
Life sciences-focused venture capital firm Epidarex Capital has hit a £102m final close for its third fund.
